Levmentin (Amoxicillin, Clavulanic Acid)

Levmentin (amoxicillin and clavulanic acid) is used to treat bacterial infections across several organ systems.

• Community‑acquired respiratory tract infections: reduces bacterial load and improves clinical symptoms.
• Urinary tract infections: eradicates common uropathogens and resolves infection signs.
• Skin and soft‑tissue infections: combats Staphylococcus and Streptococcus species causing cellulitis and abscesses.
• Intra‑abdominal infections: provides coverage for mixed aerobic and anaerobic organisms.
• Severe bacterial infections requiring IV therapy: delivers rapid, high‑concentration drug levels for critically ill patients.

• Amoxicillin binds to penicillin‑binding proteins, inhibiting the final stages of bacterial cell‑wall peptidoglycan synthesis, which leads to cell lysis. Clavulanic acid, a β‑lactamase inhibitor, protects amoxicillin from enzymatic degradation by β‑lactamase‑producing bacteria, thereby extending the antimicrobial spectrum of the combination.

Levmentin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: often self‑limiting, may be watery.
• Rash: maculopapular skin eruption.
• Injection‑site pain: localized discomfort after IV administration.
• Elevated liver enzymes: transient increase in ALT/AST.
• Headache: mild, transient.

Serious or Rare Side Effects

• Anaphylaxis: severe, potentially life‑threatening allergic reaction.
• Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin and mucous membrane involvement.
• Clostridioides difficile‑associated colitis: severe diarrhea with pseudomembranous colitis.
• Hepatic dysfunction: jaundice, hepatitis.
• Neutropenia or agranulocytosis: marked reduction in white blood cells.
• Seizures: rare, especially in patients with renal impairment or high doses.

Before initiating therapy, clinicians should consider several safety aspects.

• Allergy assessment: verify no known hypersensitivity to penicillins or β‑lactamase inhibitors.
• Liver function monitoring: check baseline transaminases and repeat if clinically indicated.
• Renal dose adjustment: reduce dosage in patients with moderate to severe renal impairment.
• Pregnancy safety: category B; use only if benefits outweigh potential risks.
• Contraindication in severe hypersensitivity: avoid in patients with a history of anaphylaxis to β‑lactams.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levmentin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Probenecid: decreases renal excretion of amoxicillin, increasing plasma concentrations and risk of toxicity.
• Methotrexate: may reduce clearance of methotrexate, heightening hematologic and hepatic toxicity.

Moderate Interactions (Monitor Closely)

• Oral anticoagulants (e.g., warfarin): may enhance anticoagulant effect; monitor INR.
• Oral contraceptives: antibiotics can reduce contraceptive efficacy; advise backup method.
• Allopurinol: increased risk of rash; monitor skin reactions.